Roche Buys Shares In Tender Offer For InterMune

(RTTNews) - Roche (RHHBY) and InterMune, Inc. (ITMN) said Roche's wholly owned subsidiary Klee Acquisition Corp. has accepted for payment all shares validly tendered, following its tender offer for all outstanding shares of common stock of InterMune at $74 per share in cash.

The tender offer expired at 12:00 midnight, New York City time, at the end of the day on September 26, and was not extended.

As of the expiration of the tender offer, a total of 96,362,877 shares of InterMune common stock were validly tendered and not withdrawn, representing around 79.42 percent of InterMune's outstanding shares on a fully diluted basis.

Later today, Roche intends to complete the acquisition of InterMune through a merger of Klee Acquisition with and into InterMune without a vote or meeting of InterMune's shareholders.

Following completion of the merger, InterMune will become a wholly owned subsidiary of Roche and InterMune's shares will cease to be traded on NASDAQ Stock Market.